4/A: Kenvue Executive Amends RSU Disclosure

Kenvue Group President APAC, Anindya Dasgupta, filed an amended Form 4 to correct an inadvertent omission of 32,649 Restricted Stock Units.

Summary

• Anindya Dasgupta, Group President APAC of Kenvue Inc., filed an amended Form 4 (Form 4/A).
• The amendment corrects an inadvertent omission from a previous Form 4 filing on August 27, 2025.
• The omitted transaction was the grant of 32,649 Restricted Stock Units (RSUs) on July 31, 2025.
• These RSUs correspond one-for-one with Kenvue's common stock.
• The award vests in three equal installments on July 31, 2026, July 31, 2027, and July 31, 2028, subject to continued service.
• The RSUs also include dividend equivalents.
• Following this reported transaction, Anindya Dasgupta beneficially owns 48,147.25 derivative securities (RSUs).

Sentiment

Score: 6

Explanation: The filing reports a routine grant of Restricted Stock Units to a senior executive, which is a positive for executive alignment. The need for an amendment due to an omission is a minor administrative negative, but the underlying event (the grant) is standard.

Positives

• The grant of 32,649 Restricted Stock Units (RSUs) to Group President APAC, Anindya Dasgupta, aligns executive interests with shareholder value.
• The RSUs include dividend equivalents, further enhancing potential value for the executive.

Negatives

• An inadvertent omission of a significant RSU grant in the original Form 4 filing required an amendment, indicating a minor administrative oversight.

Risks

• Potential for administrative errors in SEC filings, requiring amendments to ensure accurate disclosure.

Future Outlook

The granted Restricted Stock Units are scheduled to vest in three equal installments on July 31, 2026, July 31, 2027, and July 31, 2028, contingent on the reporting person's continued service.

Industry Context

This filing is a standard disclosure of executive equity compensation, common across publicly traded companies, reflecting a routine grant of Restricted Stock Units to a senior officer. Such grants are a typical component of executive incentive plans designed to align management interests with long-term shareholder value.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) to a Group President is a common practice in large consumer health companies like Kenvue, aligning with industry standards for executive compensation packages.
• Companies such as Procter & Gamble (PG) and Johnson & Johnson (JNJ) (Kenvue's former parent) frequently utilize similar equity-based incentives to retain and motivate key executives.
• The vesting schedule over three years is also typical for such awards in the sector.

Stakeholder Impact

• Shareholders: Executive equity ownership aligns the interests of the Group President APAC with those of the shareholders, potentially fostering long-term value creation.
• Employees: Standard executive compensation practices, including RSU grants, can influence overall employee morale and retention strategies within the company.

Next Steps

• Continued service of the reporting person through the vesting dates (July 31, 2026, July 31, 2027, July 31, 2028) for the RSUs to fully vest.

Key Dates

Recommendation

This Form 4/A filing primarily serves as a correction to an executive's equity compensation disclosure, specifically regarding a grant of Restricted Stock Units. It does not contain new material information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The RSU grant itself is a standard component of executive compensation, aligning management interests with long-term shareholder value, but it's not a catalyst for a 'buy' or 'sell' decision. Therefore, a 'hold' recommendation is appropriate as the filing does not alter the fundamental investment outlook for Kenvue.

Keywords

Kenvue, KVUE, Anindya Dasgupta, Form 4, SEC filing, Restricted Stock Units, RSU, executive compensation, insider transaction